<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Adamantiades-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease (ABD) is characterised by oral and <z:e sem="disease" ids="C0151281" disease_type="Disease or Syndrome" abbrv="">genital ulcerations</z:e>, <z:mp ids='MP_0001212'>skin lesions</z:mp> and ocular manifestations and, rarely, by central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) involvement </plain></SENT>
<SENT sid="1" pm="."><plain>Neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease (NBD) is categorised to parenchymal or non-parenchymal, while combined <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disease is rarely reported in the literature </plain></SENT>
<SENT sid="2" pm="."><plain>A case of NBD, with severe relapsing ocular and <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disease</z:e> of combined pattern is presented </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological complications included brainstem manifestations, as well as neurovascular involvement, while ocular involvement consisted of bilateral <z:hpo ids='HP_0000554'>uveitis</z:hpo> and branch <z:chebi fb="46" ids="15035">retinal</z:chebi> vein occlusion </plain></SENT>
<SENT sid="4" pm="."><plain>Manifestations responded to <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> plus <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> pulse therapy </plain></SENT>
<SENT sid="5" pm="."><plain>Maintenance therapy included <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A, <z:chebi fb="2" ids="2948">azathioprine</z:chebi> and <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Case individualities are discussed, focusing on scepticism concerning treatment of NBD relapses in the long term </plain></SENT>
</text></document>